GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
52.51 -0.31  -0.59% NYSE Apr 17, 8:00PM BATS Real time Currency in USD

GlaxoSmithKline News

Edit Sources
GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based therapy is considered inappropriate
PR Newswire 04/17 17:24 ET

LONDON, April 17, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) and Genmab A/S (OMX: GEN) announced today that the U.S. Food and Drug Administration (FDA) has approved a Supplemental Biologic License ...

Glaxo Looking into Misconduct Charges - Analyst Blog
Zacks 04/17 13:35 ET

GlaxoSmithKline recently responded to investigations and charges of misconduct in Jordan and Lebanon.

GSK announces approval in Canada for Incruse™ Ellipta™ (umeclidinium) as a treatment for COPD
CNW Group 04/17 13:04 ET

GSK announces approval in Canada for Incruse™ Ellipta™ (umeclidinium) as a treatment for COPD

GSK Says Incruse Gets Approval in Canada for Treatment of Lung Diseases
Dow Jones 04/17 12:30 ET

LONDON--Canada has granted GlaxoSmithKline PLC's (GSK.LN) Incruse Ellipta drug its first marketing authorization for the treatment of lung diseases, the British pharmaceutical company said Thursday.

[$$] Glaxo Investigating Bribery Claims in Jordan and Lebanon
The Wall Street Journal 04/16 22:47 ET

British pharmaceuticals giant is examining accusations its employees bribed doctors by offering perks such as flexible travel arrangements and free samples—the latest in a series of allegations about its ...

New Glaxo bribery inquiries
Yahoo 04/16 19:09 ET

Glaxo's Tanzeum Approved in the U.S. - Analyst Blog
Zacks 04/16 18:33 ET

Glaxo gained approval in the U.S. as an adjunct to diet and exercise in adults suffering from type II diabetes.

ADR Shares End Higher; Credit Suisse, ASML Shares Active
Dow Jones 04/16 18:00 ET

International stocks trading in New York closed higher Wednesday, with the Bank of New York index of American depositary receipts adding 1% to 151.29. The European index rose 0.9% to 151.22, the Asian index climbed 1.2% to 142.54, the Latin ...

Dynavax Starts Phase III Study on Heplisav-B - Analyst Blog
Zacks 04/16 16:10 ET

Dynavax Technologies commenced a new phase III study (HBV-23) on its hepatitis B vaccine candidate, Heplisav-B

Glaxo Investigating Bribery Claims in Jordan and Lebanon
Dow Jones 04/16 14:05 ET

GlaxoSmithKline PLC is investigating claims its employees bribed doctors in Jordan and Lebanon by offering perks such as flexible travel arrangements and free samples that doctors could sell on, according to emails reviewed by The Wall ...

{{article.title}} {{article.title}}
{{article.source}} {{article.time}}

{{article.summary}}

Get News for
Advertisement

Recent Quotes

Symbol Price Chg Chg % Market Cap
GSK 52.51 -0.31 -0.59% 127.46B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.